Filtered By:
Management: Funding
Countries: France Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 41 results found since Jan 2013.

‘Ridiculous,’ says Chinese scientist accused of being pandemic’s patient zero
A scientist at China’s Wuhan Institute of Virology (WIV) who has recently faced media allegations that he was the first person with COVID-19 and his research on coronaviruses sparked the pandemic strongly denies that he was ill in late 2019 or that his work had any link to the emergence of SARS-CoV-2. “The recent news about so-called ‘patient zero’ in WIV are absolutely rumors and ridiculous,” Ben Hu emailed Science in his first public response to the charges, which have been attributed to anonymous former and current U.S. Department of State officials. A WIV colleague who has also been named as one of...
Source: Science of Aging Knowledge Environment - June 23, 2023 Category: Geriatrics Source Type: research

Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
Therapie. 2023 Mar 7:S0040-5957(23)00050-1. doi: 10.1016/j.therap.2023.03.002. Online ahead of print.ABSTRACTThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) pandemic virus was a "health crisis" and a significant burden also for the French pharmacovigilance system. It took its toll in 2 phases, the first being in early 2020 when very little was known, and during which the missions of the 31 Regional Pharmacovigilance Centers (RPVCs) from university hospitals were to detect adverse reactions of drugs used in the context of the disease. Whether as a possible aggravating role on COVID-19, or displaying a differ...
Source: Therapie - April 3, 2023 Category: Psychiatry & Psychology Authors: Annie Pierre Jonville-Bera Sophie Gautier Jo ëlle Micallef Nathalie Massy Marina Atzenhoffer Aur élie Grandvuillemin Milou-Daniel Drici French Network of Regional Pharmacovigilance Centres Source Type: research

Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: a win-win bet with Health Authorities!
Therapie. 2023 Feb 22:S0040-5957(23)00046-X. doi: 10.1016/j.therap.2023.02.009. Online ahead of print.ABSTRACTThe pandemic subsequent to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus resulted, for the French institutional pharmacovigilance, in a "health crisis" in 2 phases: the coronavirus disease 2019 - "COVID-19" phase during which the missions of the Regional Pharmacovigilance Centres (RPVC) were to detect a possible impact of drugs on this disease, as whether existed a possible aggravating role of certain drugs, or the safety profile of drugs used for the management of COVID-19 could evolve. Th...
Source: Therapie - March 8, 2023 Category: Psychiatry & Psychology Authors: Annie Pierre Jonville-Bera Sophie Gautier Jo ëlle Micallef Nathalie Massy Marina Atzenhoffer Milou-Daniel Drici Aur élie Grandvuillemin R éseau français des centres régionaux de pharmacovigilance Source Type: research

The Macro View – Health, Economics, and Politics and the Big Picture. What I Am Watching Here And Abroad.
September 22, 2022 Edition-----We will see the closure on the Mourning Period for QE!! In Australia tomorrow, We can then move on to the next big issue, which will surely be the progress in the Russo-Ukrainian war and the associated issues with China and Russia.The US seems – with the rest of the world – to be moving into recession.King Charles has now been to all his UK Realms and will now quietly let PM Trass get back to running the UK. God help her …In Australia we have to now get on with life and the economic disaster we seem to be facing.-----Major Issues.-----https://www.afr.com/politics/federal/oddly-enough-th...
Source: Australian Health Information Technology - September 22, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

News at a glance: New gene therapy, Europe ’s drought, and a black hole’s photon ring
ARCHAEOLOGY Drought exposes ‘Spanish Stonehenge’ for study Scientists are rushing to examine a 7000-year-old stone circle in central Spain that had been drowned by a reservoir for decades and was uncovered after the drought plaguing Europe lowered water levels. Nicknamed the “Spanish Stonehenge”—although 2000 years older than the U.K. stone circle—the Dolmen of Guadalperal (above) was described by archaeologists in the 1920s. The approximately 100 standing stones, up to 1.8 meters tall and arranged around an oval open space, were submerged in the Valdecañas reservoir after the construction of a ...
Source: Science of Aging Knowledge Environment - August 25, 2022 Category: Geriatrics Source Type: research

News at a glance: Debate over classifying research, giant water lilies, and new hummingbird feather colors
ECOLOGY Scientists find new hummingbird colors The plumage of hummingbirds has more color diversity than the feathers of all other birds combined, a recent study finds. Researchers from Yale University collected feathers from specimens of 114 hummingbird species and, using a spectrometer, documented the wavelengths of light they reflected. These wavelengths were then compared with those found in a previous study of 111 other bird species, including penguins and parrots. The researchers were surprised to find new colors in the hummers, which widened the known avian color gamut by 56% and included rarely seen ...
Source: ScienceNOW - July 6, 2022 Category: Science Source Type: news

As COVID-Era Restrictions End, Disabled Americans Want to Avoid a ‘Return to Normal’
President Joe Biden hired Kim Knackstedt in early 2021 to make sure that Americans with disabilities were not forgotten as the country returned to normal after the COVID-19 pandemic. A year later, that seems to be precisely what has happened—and it’s unfortunate, Knackstedt says. “What was considered ‘normal’ was actually not a great way to live, often,” says Knackstedt, who served as the first White House director of disability policy, before leaving the administration on March 11. “It wasn’t accessible. It actually didn’t provide all of the things that we needed to ge...
Source: TIME: Health - April 15, 2022 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized COVID-19 Source Type: news

Johnson & Johnson and Distributors Finalize Landmark $26 Billion Opioid Settlement
(Camden, N.J.) — Drugmaker Johnson & Johnson and three major distributors finalized nationwide settlements over their role in the opioid addiction crisis Friday, an announcement that clears the way for $26 billion to flow to nearly every state and local government in the U.S. Taken together, the settlements are the largest to date among the many opioid-related cases that have been playing out across the country. They’re expected to provide a significant boost to efforts aimed at reversing the crisis in places that have been devastated by it, including many parts of rural America. Johnson & Johnson, Amer...
Source: TIME: Health - February 25, 2022 Category: Consumer Health News Authors: Geoff Mulvihill / AP Tags: Uncategorized Addiction Drugs healthscienceclimate News Desk wire Source Type: news

U.S. to Mandate COVID-19 Vaccines or Weekly Tests for Tens of Millions of Employees Next Year
Tens of millions of Americans who work at companies with 100 or more employees will need to be fully vaccinated against COVID-19 by Jan. 4 or get tested for the virus weekly under government rules issued Thursday. The new requirements, which were first previewed by President Joe Biden in September, will apply to about 84 million workers at medium and large businesses, although it is not clear how many of those employees are unvaccinated. The Occupational Safety and Health Administration regulations will force the companies to require that unvaccinated workers test negative for COVID-19 at least once a week and wear a mask ...
Source: TIME: Health - November 4, 2021 Category: Consumer Health News Authors: DAVID KOENIG/AP Tags: Uncategorized Vaccines wire Source Type: news

A Post-COVID-19 Recovery will not be Possible if Water, Sanitation & Hygiene are not High on the Agenda
Michael, 34, a nurse at Wurm CHPS, Ghana, washes his hands. Every healthcare centre in the world’s poorest countries could have taps and toilets for just half-an-hour’s worth of COVID-19 spending. Credit: WaterAid / Apagnawen AnnankraBy Helen HamiltonLONDON, Apr 7 2021 (IPS) This World Health Day, G20 finance ministers will meet in Rome, Italy, to discuss how they will build back from the pandemic. The global economy is and concerted effort, coordination and imagination is needed to enable not only a worldwide recovery but also to ensure that the world’s poorest people are not left behind. The World Health Organiza...
Source: IPS Inter Press Service - Health - April 7, 2021 Category: International Medicine & Public Health Authors: Helen Hamilton Tags: Development & Aid Education Environment Global Headlines Health Humanitarian Emergencies Inequity Poverty & SDGs Sustainability TerraViva United Nations Water & Sanitation Source Type: news

End Vaccine Apartheid Before Millions More Die
By Anis Chowdhury and Jomo Kwame SundaramSYDNEY and KUALA LUMPUR, Mar 23 2021 (IPS) At least 85 poor countries will not have significant access to coronavirus vaccines before 2023. Unfortunately, a year’s delay will cause an estimated 2.5 million avoidable deaths in low and lower-middle income countries. As the World Health Organization (WHO) Director-General has put it, the world is at the brink of a catastrophic moral failure. Anis Chowdhury Vaccine apartheid The EU, US, UK, Switzerland, Canada and their allies continue to block the developing country proposal to temporarily suspend the World Trade Organization (WTO) ...
Source: IPS Inter Press Service - Health - March 23, 2021 Category: International Medicine & Public Health Authors: Anis Chowdhury and Jomo Kwame Sundaram Tags: Development & Aid Economy & Trade Featured Global Headlines Health Human Rights Humanitarian Emergencies TerraViva United Nations Source Type: news

NIH Director Francis Collins Is Fighting This Coronavirus While Preparing for the Next One
In May 2020, Dr. Francis Collins, the longtime head of the National Institutes of Health (NIH), was called to the White House to meet with Jared Kushner, the then President’s son-in-law and adviser, and Dr. Deborah Birx, the head of the White House Coronavirus Task Force. A few weeks earlier, Congress had given the NIH $1.5 billion to try to speed up the process of developing new diagnostic tests for COVID-19, and the White House, which was dubious about increasing the rate of testing, wanted to know more about what the NIH was doing. Collins is technically the boss of Dr. Anthony Fauci, but during the pandemic he ha...
Source: TIME: Health - February 4, 2021 Category: Consumer Health News Authors: Belinda Luscombe Tags: Uncategorized COVID-19 feature Magazine Source Type: news